Abe Yando Pharmaceutical's Journey Towards World-Class Longevity Solutions
Abe Yando Pharmaceutical Co., Ltd. is making headlines with its groundbreaking attempts to improve human longevity. Headquartered in Tokyo, the company, led by President Tomotaka Abe, was recently recognized as a semi-finalist in the "XPRIZE Healthspan," a prestigious global scientific competition with a prize pool exceeding 15 billion yen (approximately $137 million). This competition invites teams from around the world to explore innovative solutions to significantly extend healthy life expectancy—markedly by at least ten years through advancements in muscle, cognitive, and immune functions.
In the most recent developments, Abe Yando Pharmaceutical harnessed its expertise as a pioneer in the domestic research of Nicotinamide Mononucleotide (NMN)—a compound increasingly recognized for its potential to rejuvenate biological functions. Conducting clinical trials specifically designed to align with the competition’s evaluation criteria, the company divided participants aged between 47 to 65 into two distinct groups: one receiving NMN-infused herbal drinks and the other a placebo. Over 42 days of monitored intake, the team assessed various health markers associated with aging, particularly muscle strength, cognitive abilities, and immune functionality.
The results of the trial were promising, reflecting significant advancements in the participants’ overall health. The intervention group demonstrated increased physical activity levels alongside improvements in memory retention and processing speed. Markedly, the trial produced noteworthy declines in inflammatory markers, particularly Interleukin-6 (IL-6), while also fostering an increase in Interleukin-10 (IL-10), a critical component that typically diminishes with age.
Further analysis based on extensive aging datasets, such as the Baltimore Longitudinal Study of Aging, revealed an estimated functional age reduction of about 2.8 years in the intervention group. In terms of biological aging, DNA methylation analyses indicated an average rejuvenation of around four years—one participant even showed an impressive improvement of up to thirteen years. The findings from this clinical trial indicate a tangible trajectory towards not only feeling younger but also indicating a molecular shift towards enhanced vitality within a short span of 42 days.
Looking forward, Abe Yando Pharmaceutical is gearing up for larger-scale clinical trials in collaboration with international research institutions, ensuring a robust and thorough investigation into the potentials of longevity science. The official announcement of the final results for the XPRIZE Healthspan is anticipated on August 11, 2026. The company's commitment lies rooted in a deep tradition of health management that dates back to its inception in 1731. By effectively marrying the wisdom of Eastern medicine with Western scientific understanding, Abe Yando continues to explore innovative pathways for promoting health and longevity.
Headquartered at the YAK Kitakoi Building in Adachi, Tokyo, the company has upheld a unique legacy for nearly 300 years. It operates with a philosophy that balances traditional health practices and cutting-edge research and will continue to innovate within this vital field of health and wellness.
For further details, visit their official website at https://corp.abeyoando.co.jp/ or reach out to their Public Relations department via email at [email protected].
In the most recent developments, Abe Yando Pharmaceutical harnessed its expertise as a pioneer in the domestic research of Nicotinamide Mononucleotide (NMN)—a compound increasingly recognized for its potential to rejuvenate biological functions. Conducting clinical trials specifically designed to align with the competition’s evaluation criteria, the company divided participants aged between 47 to 65 into two distinct groups: one receiving NMN-infused herbal drinks and the other a placebo. Over 42 days of monitored intake, the team assessed various health markers associated with aging, particularly muscle strength, cognitive abilities, and immune functionality.
The results of the trial were promising, reflecting significant advancements in the participants’ overall health. The intervention group demonstrated increased physical activity levels alongside improvements in memory retention and processing speed. Markedly, the trial produced noteworthy declines in inflammatory markers, particularly Interleukin-6 (IL-6), while also fostering an increase in Interleukin-10 (IL-10), a critical component that typically diminishes with age.
Further analysis based on extensive aging datasets, such as the Baltimore Longitudinal Study of Aging, revealed an estimated functional age reduction of about 2.8 years in the intervention group. In terms of biological aging, DNA methylation analyses indicated an average rejuvenation of around four years—one participant even showed an impressive improvement of up to thirteen years. The findings from this clinical trial indicate a tangible trajectory towards not only feeling younger but also indicating a molecular shift towards enhanced vitality within a short span of 42 days.
Looking forward, Abe Yando Pharmaceutical is gearing up for larger-scale clinical trials in collaboration with international research institutions, ensuring a robust and thorough investigation into the potentials of longevity science. The official announcement of the final results for the XPRIZE Healthspan is anticipated on August 11, 2026. The company's commitment lies rooted in a deep tradition of health management that dates back to its inception in 1731. By effectively marrying the wisdom of Eastern medicine with Western scientific understanding, Abe Yando continues to explore innovative pathways for promoting health and longevity.
Headquartered at the YAK Kitakoi Building in Adachi, Tokyo, the company has upheld a unique legacy for nearly 300 years. It operates with a philosophy that balances traditional health practices and cutting-edge research and will continue to innovate within this vital field of health and wellness.
For further details, visit their official website at https://corp.abeyoando.co.jp/ or reach out to their Public Relations department via email at [email protected].
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.